The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial

by Rhea N. Coler, Tracey A. Day, Ruth Ellis, Franco M. Piazza, Anna Marie Beckmann, Julie Vergara, Tom Rolf, Lenette Lu, Galit Alter, David Hokey, Lakshmi Jayashankar, Robert Walker, Margaret Ann Snowden, Tom Evans, Ann Ginsberg, Steven G. Reed, The TBVPX-113 Study Team
Published 2018-09-01

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

by Margherita Coccia, Catherine Collignon, Caroline Hervé, Aurélie Chalon, Iain Welsby, Sophie Detienne, Mary J. van Helden, Sheetij Dutta, Christopher J. Genito, Norman C. Waters, Katrijn Van Deun, Age K. Smilde, Robert A. van den Berg, David Franco, Patricia Bourguignon, Sandra Morel, Nathalie Garçon, Bart N. Lambrecht, Stanislas Goriely, Robbert van der Most, Arnaud M. Didierlaurent
Published 2017-09-01

Protein nanovaccine confers robust immunity against Toxoplasma

by Kamal El Bissati, Ying Zhou, Sara Maria Paulillo, Senthil Kumar Raman, Christopher P. Karch, Craig W. Roberts, David E. Lanar, Steve Reed, Chris Fox, Darrick Carter, Jeff Alexander, Alessandro Sette, John Sidney, Hernan Lorenzi, Ian J. Begeman, Peter Burkhard, Rima McLeod
Published 2017-09-01

A Plasmodium berghei sporozoite-based vaccination platform against human malaria

by António M. Mendes, Marta Machado, Nataniel Gonçalves-Rosa, Isaie J. Reuling, Lander Foquet, Cláudia Marques, Ahmed M. Salman, Annie S. P. Yang, Kara A. Moser, Ankit Dwivedi, Cornelus C. Hermsen, Belén Jiménez-Díaz, Sara Viera, Jorge M. Santos, Inês Albuquerque, Sangeeta N. Bhatia, John Bial, Iñigo Angulo-Barturen, Joana C. Silva, Geert Leroux-Roels, Chris J. Janse, Shahid M. Khan, Maria M. Mota, Robert W. Sauerwein, Miguel Prudêncio
Published 2018-08-01